Neuer Vorstand der MEDTRON AG Markus Bappert lächelnd

Leadership Changes at MEDTRON AG

Saarbruecken, 11/12/2023 - The Supervisory Board of MEDTRON AG announces a change in the management of the company. Since December 11, 2023, Markus Bappert will lead the MEDTRON AG as sole director.

Markus Bappert is the successor of Martin Biehl and Björn Jochems, who left the company on December 8, 2023.

As one of his first tasks, Markus Bappert will work together with the management team of MEDTRON AG to define the company's goals more transparently and to realign the corporate culture in order to further strengthen the company's performance.

We are confident that Markus Bappert, with his many years of experience and expertise, will release new forces within MEDTRON AG to enable a sustainable and successful future development.

MEDTRON AG is a globally active company working in the field of medical engineering. As one of the leading manufacturers of ultramodern contrast medium injectors, MEDTRON AG has made its name on the international market: Across the globe, many thousand doctors, hospitals and diagnostic centres place their trust in MEDTRON’s contrast media injectors made in Germany. Our innovative and high-quality injector complement virtually all modern methods of examination which can be performed with the help of medical engineering imaging systems, such as magnetic resonance imaging, computed tomography and angiography.